| View previous topic :: View next topic |
Post subject:
|
Posted: Tue Jul 08, 2008 11:02 am
|
|
|
|
Mod Troy
Administrators
Joined: 27 Apr 2007
Posts: 118
|
|
|
|
|
|
|
 |
Post subject:
|
Posted: Thu Jul 10, 2008 11:05 am
|
|
|
|
Mod Troy
Administrators
Joined: 27 Apr 2007
Posts: 118
|
|
|
|
|
All spam bots that posted = banned.
|
|
|
|
|
|
|
Post subject: EMEA Recommends a New foreshadowing for Epoetin for Thueir U
|
Posted: Sun Jul 13, 2008 9:39 am
|
|
|
|
PettyDafLotte
New Member
Joined: 02 Jul 2008
Posts: 3
Location: Bermudb
|
|
|
|
|
LONDON, June 4, 2008-The European Medicines instrumentality (EMEA) has rceommended updating the produce intelligence for epoetin-containing medicines with a new threat for their use in cancer patients stating that blood transfusion should be the preferred method of correcting anaemia in patients hardship cancer.
Epoetin-contaaining medicines are indicated in patients wiith covet-lastingnon-starter and for the treatmetn of anaemia in symptomatic aptients with non-myeloid growths receiving chemotherapy. The instrumentality’s board for remedial Products for Good Samaritzn Use (CHMP) had noticeed new details from studies that showed an increased endanger of growth acheter cialis generique ascension, vennous thromboembolism and shorter inclusive survival in cancer patients who experienced epoetins compared to patients who did not clear themn. Following this rehashing, the CHMP concludde, at its June 2008 conference, that the gains of epoetins persist surpass their endangers in the approved indications. on the other hand, in cancer patients with a reasonably great flair-expectancy, the emoluments of using epoetins does not surpass the hazawrd growth devleopment and shorter alli-nclusive survival and consequently the couincil concluded that in these patients anaemia should be corrected with blood transfusions.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
